Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-25-001740
Filing Date
2025-01-16
Accepted
2025-01-16 16:45:18
Documents
5
Effectiveness Date
2025-01-16

Document Format Files

Seq Description Document Type Size
1 S-8 a012025s-8.htm S-8 72788
2 EX-FILING FEES ex107calculationoffilingfe.htm EX-FILING FEES 15760
3 EX-5.1 xforex51jan162025.htm EX-5.1 8667
4 EX-23.1 ex_231xpwcconsentjan162025.htm EX-23.1 2372
5 goodwina.jpg GRAPHIC 10905
  Complete submission text file 0001628280-25-001740.txt   115891
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-284320 | Film No.: 25536167
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)